Organization

ARAMIS Postmarketing Surveillance Program

1 abstract

Abstract
AGE AND RISK OF NSAID-INDUCED UPPER GASTROINTESTINAL (UGI) SYMPTOMS: ANALYSIS OF SUCCESS I, A DOUBLE BLIND, RANDOMIZED, CONTROLLED TRIAL IN 13,194 PATIENTS WITH OSTEOARTHRITIS (OA)
Org: ARAMIS Postmarketing Surveillance Program, Stanford University Medical Center, Stanford, CA, Palo Alto University, Professor of Medicine, University of Illinois at Chicago,